COVID-19 Evidence presented by InpharmD™-logo

COVID-19 Evidence presented by InpharmD™

Health & Wellness Podcasts

Lit Covid lists more than 10,000 COVID-19 studies and hundreds more are added daily. We parse through them and give you the evidence you need to know here, every week.

Lit Covid lists more than 10,000 COVID-19 studies and hundreds more are added daily. We parse through them and give you the evidence you need to know here, every week.

Location:

United States

Description:

Lit Covid lists more than 10,000 COVID-19 studies and hundreds more are added daily. We parse through them and give you the evidence you need to know here, every week.

Language:

English


Episodes

Anaphylaxis after Pfizer Vaccine

2/26/2021
Early data suggests the incidence of true anaphylaxis to the Pfizer-BioNTech COVID-19 vaccine is rare (11.1 cases per million vaccine doses). Anaphylaxis is more common in women and persons with a history of allergies, and symptoms typically appear within 30 minutes of injection.

Duration:00:06:50

Association of Psychiatric Disorders and COVID-19

2/19/2021
A retrospective, observational, cohort study done to assess whether a diagnosis of a schizophrenia spectrum disorder, mood disorder, or anxiety disorder is associated with mortality in patients with COVID-19.

Duration:00:05:57

Preliminary Data on Johnson and Johnson Vaccine

2/8/2021
A randomized, multicenter, double-blind, placebo-controlled, phase 1/2a clinical trial to evaluate the safety, reactogenicity, and immunogenicity of Ad26.COV2.S - a recombinant, replication-incompetent adenovirus serotype 26 (Ad26) vector encoding a full-length and stabilized SARS-CoV-2 spike (S) protein

Duration:00:08:07

Clinical Characteristics of COVID-19 in Hematopoietic Stem-Cell Transplantation Recipients

2/1/2021
An observational cohort study performed to describe characteristics and outcomes of hematopoietic stem-cell transplantation (HSCT) recipients after developing COVID-19

Duration:00:08:15

Continuation versus discontinuation of RAAS inhibitors in hospitalized patients with COVID-19

1/25/2021
A prospective, randomized, open-label trial performed to evaluate whether continuation of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) is beneficial or harmful in patients who are admitted to hospital with COVID-19.

Duration:00:05:32

Comparative Differences Between COVID-19 and Seasonal Influenza

1/19/2021
A cohort study done to comparatively examine differences in risk of clinical manifestations and death among people admitted to hospital with coronavirus disease 2019 (COVID-19) and seasonal influenza.

Duration:00:05:28

Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with COVID-19 and seasonal influenza: cohort study

1/19/2021
A cohort study done to comparatively examine differences in risk of clinical manifestations and death among people admitted to hospital with coronavirus disease 2019 (COVID-19) and seasonal influenza

Duration:00:05:19

Efficacy and Safety of the Moderna mRNA-1273 SARS-CoV-2 Vaccine to Prevent COVID-19

1/12/2021
A phase 3 randomized, stratified, observer-blinded, placebo-controlled trial to to assess the safety and efficacy of the mRNA-1273 vaccine in preventing SARS-CoV-2 infection.

Duration:00:09:30

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19 (ACTT-2)

1/4/2021
A randomized, multicenter, adaptive, double-blind, placebo-controlled trial to evaluate whether the combination of baricitinib plus remdesivir was superior to remdesivir alone.

Duration:00:06:36

Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic

12/28/2020
A comparative study done to evaluate the fitted filtration efficiency (FFE) of various consumer-grade and improvised face masks, as well as several popular modifications of medical procedure masks that are intended to improve mask fit or comfort.

Duration:00:06:08

Simultaneous COVID-19 in Homozygous Twins

12/22/2020
A case report describing two monozygotic twins with different clinical courses, despite having the same environment and genomic factors.

Duration:00:06:30

Adjusted BMI and risk of death due to COVID-19

12/17/2020
A retrospective, cohort study conducted to determine the adjusted effect of body mass index (BMI), associated comorbidities, time, neighborhood-level sociodemographic factors, and other factors on risk for death due to COVID-19

Duration:00:06:00

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomized, double-blind, placebo-controlled, phase 2 trial

12/9/2020
A randomzied, double-blind, placebo-controlled, multicenter, phase 2, pilot trial conducted to determine whether inhaled SNG001 (recombinant interferon beta-1a) has the potential to reduce the severity of lower respiratory tract illness and accelerate recovery in patients diagnosed with COVID-19.

Duration:00:06:57

Bamlanivimab - SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

11/27/2020
The purpose of this study was to evaluate the efficacy and safety of LY-CoV555 (bamlanivimab) in patients with recently diagnosed mild or moderate COVID-19 in the outpatient setting

Duration:00:08:04

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

11/19/2020
What does the evidence says on the safety and immunogenicity of pfizer's potential vaccine - BNT162b2 - as compared to other candidates?

Duration:00:07:33

Levels of Severity of Depressive Symptoms Among At-Risk Groups During COVID-19

11/12/2020
A cohort study examining levels of severity of depressive symptoms over time among individuals with high risk in the UK during the COVID-19 pandemic

Duration:00:06:08

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

11/5/2020
A randomized, double-blind, placebo-controlled trial conducted to assess if early intervention with interleukin-6 receptor blockade might limit COVID-19 progression to hypoxemic respiratory failure or death, reduce the risk of clinical worsening, and decrease the duration of supplemental oxygen use.

Duration:00:05:51

Genomic evidence for reinfection with SARS-CoV-2: a case study

10/27/2020
A 25-year old male patient was infected on two separate occasions, with the second infection being symptomatically more severe than the first. Genomic analysis showed the two viral agents were genetically distinct.

Duration:00:06:33

Remdesivir for the Treatment of Covid-19 — Final Report

10/22/2020
The objective of this study was to evaluate the clinical efficacy and safety of remdesivir among hospitalized adults with laboratory-confirmed COVID-19.

Duration:00:07:10

Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of COVID-19 in SARS-CoV-2 infected male patients: a cohort study

10/16/2020
The objective of the cohort study was to investigate the effect of serum testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 in SARS-CoV-2 infected male patients

Duration:00:06:38